Literature DB >> 9422033

Immunological mechanisms in atherosclerosis.

T Yokota1, G K Hansson.   

Abstract

Immunological mechanisms seem to be potent modulators of the atherosclerotic process. The presence of substantial numbers of T-lymphocytes in the lesion and local and circulating autoantibodies to plaque components suggests that a specific immune response is operating. Focal expression of adhesion molecules and local secretion of chemoattractants could mediate the recruitment of inflammatory cells to the lesion. Local cytokine and growth factor networks may operate later, controlling cell migration and proliferation. Although it is still important to realize the complexity of these mechanisms, the ongoing characterization of the molecular mechanisms in atherogenesis may lead to new strategies for intervention with the disease process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9422033     DOI: 10.1111/j.1365-2796.1995.tb01229.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes.

Authors:  J B De Sanctis; I Blanca; H Rivera; N E Bianco
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

2.  Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins.

Authors:  J B De Sanctis; I Blanca; N E Bianco
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Authors:  J C Pickup; M B Mattock; G D Chusney; D Burt
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

4.  Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques.

Authors:  T J Reape; K Rayner; C D Manning; A N Gee; M S Barnette; K G Burnand; P H Groot
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

5.  Inhibitory effects of lysophosphatidylcholine on the dopaminergic system.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Kennie R Shepherd; Nazarius S Lamango; Karam F A Soliman; Clivel G Charlton
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

6.  Quantum dot mediated imaging of atherosclerosis.

Authors:  Ashwath Jayagopal; Yan Ru Su; John L Blakemore; MacRae F Linton; Sergio Fazio; Frederick R Haselton
Journal:  Nanotechnology       Date:  2009-03-31       Impact factor: 3.874

7.  Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Authors:  Lin Ma; Hitoshi Uchida; Jun Nagai; Makoto Inoue; Jerold Chun; Junken Aoki; Hiroshi Ueda
Journal:  Mol Pain       Date:  2009-11-13       Impact factor: 3.395

8.  Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.

Authors:  Makoto Inoue; Lin Ma; Junken Aoki; Jerold Chun; Hiroshi Ueda
Journal:  Mol Pain       Date:  2008-02-08       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.